Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cells and diabetes.

G Berná1, T León-Quinto, R Enseñat-Waser

  • 1Institute of Bioengineering, University Miguel Hernández, Alicante, Spain

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses.

Frontiers in cell and developmental biology·2023
Same author

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol.

Trials·2021
Same author

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial.

NPJ digital medicine·2021
Same author

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE).

EClinicalMedicine·2021
Same author

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study.

Scientific reports·2021
Same author

SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy.

Frontiers in cell and developmental biology·2021
Same journal

Corrigendum to "Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells" [Biomed. Pharmacother. 189 (2025) 118279].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum: "Zebrafish as a model to study inflammation: A tool for drug discovery" [Biomed. Pharmacother. 144 (2021) 112310].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Raloxifene and tamoxifen reshape the immunometabolic phenotype of TLRs-activated macrophages through AEBS inhibition and lysosomal stress.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Smart biomaterials in the dimensional revolution of bioprinting: From 2D to 6D for advanced biomedical applications.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

A trispecific GLP-1/anti-GIPR/FGF21 peptibody exhibits favorable metabolic effects in a diet-induced obesity model.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Malvidin and its glycosides in cancer treatment: Mechanisms, synergies and drug delivery strategies.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Stem cell-derived islet cells offer a potential cure for diabetes, overcoming donor limitations and immunosuppression side effects. Research shows these cells can normalize blood glucose in diabetic animal models.

Area of Science:

  • Regenerative Medicine
  • Endocrinology
  • Cell Biology

Background:

  • Diabetes mellitus affects 2-5% of the population, with islet transplantation limited by donor scarcity and immunosuppression.
  • Stem cells, capable of self-renewal and differentiation, present a renewable source for generating therapeutic cells.
  • Ethical concerns and autotransplantation benefits favor the use of adult stem cells over embryonic sources.

Purpose of the Study:

  • To explore the potential of stem cells for generating insulin-secreting cells for diabetes treatment.
  • To address the limitations of current islet transplantation methods.
  • To evaluate the therapeutic efficacy of stem cell-derived islet cells.

Main Methods:

  • Utilizing in vitro differentiation and selection protocols for embryonic stem cells.

Related Experiment Videos

  • Employing genetic selection markers to isolate specific cell lineages.
  • Investigating the differentiation potential of adult stem cells.

    • Main Results:

    • Successful generation of embryonic stem cell-derived insulin-secreting cells.
    • Normalization of blood glucose levels in diabetic animal models following transplantation.
    • Emerging evidence suggests significant functional plasticity in adult stem cells.

    Conclusions:

    • Stem cell-derived therapies hold promise for overcoming challenges in diabetes treatment.
    • Cell therapy, particularly using stem cells, is a potential future solution for diabetes.
    • Further research into adult stem cell plasticity may offer ethical and practical advantages for autotransplantation.